Orange Book product · Brand (NDA)
ALSUMA
SUMATRIPTAN SUCCINATE
At a glance
Jun 29, 2010
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 29, 2010
16 yr 2 mo ago
Today
Patent 7811254 expires
Listed drug product patent expiration.
Aug 26, 2027
in 1 yr 2 mo
Pharmaceutical detail
Active ingredient
SUMATRIPTAN SUCCINATE
Strength
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Dosage form
INJECTABLE
Route
SUBCUTANEOUS
TE code
Not listed
Application
NDA 022377
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2016ZEMBRACE SYMTOUCHBrand (NDA)
NDA 208223 · TONIX MEDS
- 2016ONZETRA XSAILBrand (NDA)
NDA 206099 · CURRAX
- 2013SUMAVEL DOSEPROBrand (NDA)
NDA 022239 · ENDO OPERATIONS
- 2013ZECUITYBrand (NDA)
NDA 202278 · TEVA BRANDED PHARM
- 1995IMITREXBrand (NDA)
NDA 020132 · GLAXOSMITHKLINE
- 1992IMITREXBrand (NDA)
NDA 020080 · GLAXOSMITHKLINE
- 2025SUMATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 213518 · ALEMBIC
- 2025SUMATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 206019 · IPCA LABS LTD
- 2024SUMATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 219036 · VKT PHARMA
- 2024SUMATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 215651 · ONESOURCE SPECIALTY
- 2023SUMATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 207101 · BAXTER HLTHCARE CORP
- 2021SUMATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 213998 · CAPLIN
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7811254 | Aug 26, 2027 | in 1 yr 2 mo | ProductU-1083 |
